Llwytho...
Perspectives on the clinical development of immunotherapy in prostate cancer
Despite impressive survival benefits with immunotherapy in patients with various solid tumors, the full potential of these agents in prostate cancer has yet to be realized. Sipuleucel-T demonstrated a survival benefit in this population, indicating that prostate cancer is an immunoresponsive disease...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Asian J Androl |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Medknow Publications & Media Pvt Ltd
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952479/ https://ncbi.nlm.nih.gov/pubmed/29582792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aja.aja_9_18 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|